The pso Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the pso Hub cannot guarantee the accuracy of translated content. The pso and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The PsOPsA Hub is supported by educational grants. All educational content is developed independently by SES in collaboration with our expert steering committee, with no input or influence from financial supporters. We would like to express our gratitude to the following companies for their support: • UCB: For website development, launch, and ongoing maintenance. • UCB: For educational content and news updates.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View pso content recommended for you
What should shared decision-making look like in the management of psoriasis and psoriatic arthritis?
Featured:
During the 31st European Academy of Dermatology and Venereology (EADV) Congress, the Psoriasis and Psoriatic Arthritis Hub was pleased to speak to Christine Bundy, Cardiff University, Cardiff, UK. We asked, What should shared decision-making look like in the management of psoriasis and psoriatic arthritis?
Bundy begins by outlining the positive trend between health outcomes and patient involvement, and then goes through the three stages of achieving shared decision-making and the importance of providing choices between balanced treatment options.
To finish, Bundy notes the need for specific research on the impact shared decision-making has on adherence in psoriasis and psoriatic arthritis.
What should shared decision-making look like in the management of psoriasis and psoriatic arthritis?